Pages that link to "Q40574136"
Jump to navigation
Jump to search
The following pages link to Overexpression and amplification of Aurora-A in hepatocellular carcinoma (Q40574136):
Displaying 50 items.
- Aurora A, centrosome structure, and the centrosome cycle (Q24318115) (← links)
- Emerging molecular classifications and therapeutic implications for gastric cancer (Q26745525) (← links)
- Aurora Kinases and Potential Medical Applications of Aurora Kinase Inhibitors: A Review (Q26783412) (← links)
- The Non-Canonical Role of Aurora-A in DNA Replication (Q26784066) (← links)
- Advances in targeted therapies and new promising targets in esophageal cancer (Q26825957) (← links)
- Aurora kinase A in gastrointestinal cancers: time to target (Q26864277) (← links)
- Crystal structure of an Aurora-A mutant that mimics Aurora-B bound to MLN8054: insights into selectivity and drug design (Q27658934) (← links)
- Molecular mechanism of Aurora A kinase autophosphorylation and its allosteric activation by TPX2 (Q27683971) (← links)
- Correlation of Aurora-A expression with the effect of chemoradiation therapy on esophageal squamous cell carcinoma (Q27853160) (← links)
- Aurora kinase A induces miR-17-92 cluster through regulation of E2F1 transcription factor (Q28276739) (← links)
- Evolution of resistance to Aurora kinase B inhibitors in leukaemia cells (Q28480926) (← links)
- Inhibition of Aurora kinase B is important for biologic activity of the dual inhibitors of BCR-ABL and Aurora kinases R763/AS703569 and PHA-739358 in BCR-ABL transformed cells (Q28545195) (← links)
- Evaluation of the medicinal herb Graptopetalum paraguayense as a treatment for liver cancer (Q28545854) (← links)
- Global gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: similarities in the molecular landscape with human liver cancer (Q28829385) (← links)
- Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC. (Q30988387) (← links)
- Constitutive phosphorylation of aurora-a on ser51 induces its stabilization and consequent overexpression in cancer (Q33300353) (← links)
- Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathway (Q33517958) (← links)
- Characterization of the Indirubin Derivative LDD970 as a Small Molecule Aurora Kinase A Inhibitor in Human Colorectal Cancer Cells (Q33611307) (← links)
- Aurora kinase inhibitors--rising stars in cancer therapeutics? (Q33647643) (← links)
- Aurora-A signaling is activated in advanced stage of squamous cell carcinoma of head and neck cancer and requires osteopontin to stimulate invasive behavior (Q33688594) (← links)
- Targeting high Aurora kinases expression as an innovative therapy for hepatocellular carcinoma (Q33709521) (← links)
- AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer (Q33750741) (← links)
- In vitroandin vivopharmacokinetic characterizations of AMG 900, an orally bioavailable small molecule inhibitor of aurora kinases (Q33811937) (← links)
- Dysregulating IRES-dependent translation contributes to overexpression of oncogenic Aurora A Kinase. (Q33944846) (← links)
- Overexpression of Active Aurora-C Kinase Results in Cell Transformation and Tumour Formation (Q34064502) (← links)
- Identification of aurora kinase A as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumors (Q34100865) (← links)
- Danusertib, an aurora kinase inhibitor (Q34126899) (← links)
- Suppression of Aurora-A oncogenic potential by c-Myc downregulation (Q34355817) (← links)
- Aurora-A identifies early recurrence and poor prognosis and promises a potential therapeutic target in triple negative breast cancer (Q34599715) (← links)
- The aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivo. (Q34981765) (← links)
- KUD773, a phenylthiazole derivative, displays anticancer activity in human hormone-refractory prostate cancers through inhibition of tubulin polymerization and anti-Aurora A activity. (Q35005238) (← links)
- The role of centrosomal Nlp in the control of mitotic progression and tumourigenesis (Q35006781) (← links)
- Aurora-A promotes chemoresistance in hepatocelluar carcinoma by targeting NF-kappaB/microRNA-21/PTEN signaling pathway (Q35149675) (← links)
- Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer. (Q35168142) (← links)
- OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci (Q35179204) (← links)
- Overexpression of Aurora-A promotes laryngeal cancer progression by enhancing invasive ability and chromosomal instability (Q35675651) (← links)
- Aurora kinase inhibitors as anticancer molecules (Q35850203) (← links)
- Aurora-A - a guardian of poles (Q35998764) (← links)
- Reversine Induced Multinucleated Cells, Cell Apoptosis and Autophagy in Human Non-Small Cell Lung Cancer Cells (Q36069311) (← links)
- Aurora-A is an efficient marker for predicting poor prognosis in human nasopharyngeal carcinoma with aggressive local invasion: 208 cases with a 10-year follow-up from a single institution. (Q36084311) (← links)
- Transcriptomic characterization of fibrolamellar hepatocellular carcinoma (Q36268536) (← links)
- Aurora A kinase expression is increased in leukemia stem cells, and a selective Aurora A kinase inhibitor enhances Ara-C-induced apoptosis in acute myeloid leukemia stem cells (Q36297651) (← links)
- Aurora A and B kinases as targets for cancer: will they be selective for tumors? (Q36352091) (← links)
- Targeting Aurora kinases in ovarian cancer (Q36379376) (← links)
- Perimembrane Aurora-A expression is a significant prognostic factor in correlation with proliferative activity in non-small-cell lung cancer (NSCLC). (Q36462861) (← links)
- Differential proteomic alterations between localised and metastatic prostate cancer. (Q36553042) (← links)
- Vaccinia-related kinase 1 promotes hepatocellular carcinoma by controlling the levels of cell cycle regulators associated with G1/S transition (Q36557517) (← links)
- Primary cilia and aberrant cell signaling in epithelial ovarian cancer (Q36564548) (← links)
- Depletion of Aurora A leads to upregulation of FoxO1 to induce cell cycle arrest in hepatocellular carcinoma cells (Q36604655) (← links)
- p53 gene in treatment of hepatic carcinoma: status quo. (Q36764842) (← links)